Elias Quijano

Elias Quijano, PhD, is a Senior Associate at Northpond Ventures, a leading venture capital firm focused on life sciences, and serves as a Board Observer for Incendia Therapeutics. Quijano is also a Co-Founder and Senior Research Advisor at Gennao Bio, specializing in targeted nucleic acid therapeutics. Previously, Quijano held positions at Yale Ventures as a Blavatnik Fellow and Blavatnik Associate, where contributions included developing scientific plans and obtaining seed funding for biotech startups. As Co-Director of Operations at Nucleate Bio, Quijano supported bio-entrepreneurship initiatives. Quijano's background includes extensive experience as a research assistant and lab manager at Yale University, focusing on drug delivery systems, and a role as Graduate Coordinator for the STARS Program, promoting diversity in STEM fields. Quijano holds a BS in Bioengineering and Biomedical Engineering and a PhD in Genetics from Yale University.